|
Dr. Fleury was appointed as our Chief Scientific Officer in November 2003 and as a Director on January 11 2006. In addition to serving as our Chief Scientific Officer Dr. Fleury has maintained until June 2006 his academic research activity on in heart transplantation at the Department of Experimental Surgery from the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne Switzerland. Dr. Fleury moved to the CHUV in January 1997 where he initially worked as Assistant to Professor Giuseppe Pantaleo until June 2000 a leading expert in AIDS. During that time he studied the immune regeneration of HIV infected subjects under highly active anti-retroviral therapy. He then moved to the Division of Cardiology (CHUV) as Project leader for developing new research activities in gene therapy applied to heart transplantation in collaboration with Novartis and genetic studies involving chemokines and chemokine receptors in heart rejection. In January 2004 Dr. Fleury moved to the Department of Experimental Surgery directed by Professor Yann Barrandon a world leader on stem cells for completing its research on lentiviral gene therapy . Dr. Fleury obtained his B.Sc. in Microbiology in 1985 from the University of Montreal (Canada) his M.Sc. in Virology in 1988 from the Institut Armand-Frappier (Laval Canada) and his Ph.D. in 1992 from the Clinical Research Institute of Montreal in Canada with Rafick Sekaly. During his Ph.D. Dr. Fleury worked on the CD4 molecule which is the primary HIV cellular receptor. From 1993-1996 Dr. Fleury completed his postgraduate studies in Bethesda (USA) at the NIAID National Institutes of Health (NIH) with Dr. Ronald N. Germain a world renowned Immunologist. Dr. Fleury is the recipient of several awards and prizes and has published articles in his field of study in scientific journals with a high impact such as Science Cell Nature Nature Medicine Circulation. | 